| Literature DB >> 21377269 |
Maria Vougioukalaki1, Dimitris C Kanellis, Kalliopi Gkouskou, Aristides G Eliopoulos.
Abstract
The activation of mitogen-activated protein kinases (MAPKs) is critically involved in inflammatory and oncogenic events. Tumor progression locus 2 (Tpl2), also known as COT and MAP3 kinase 8 (MAP3K8), is a serine-threonine kinase with an important physiological role in tumor necrosis factor, interleukin-1, CD40, Toll-like receptor and G protein-coupled receptor-mediated ERK MAPK signaling. Whilst the full characterization of the biochemical events that lead to the activation of Tpl2 still represent a major challenge, genetic and molecular evidence has highlighted interesting interactions with the NF-κB network. Here, we provide an overview of the multifaceted functions of Tpl2 and the molecular mechanisms that govern its regulation.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21377269 DOI: 10.1016/j.canlet.2011.02.004
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679